Objectives. Despite extensive research efforts, mechanisms participating on development of Alzheimer´s disease (AD) are covered only partially. Data from the last decades indicate that various stressors, as etiological factors, may play a role of in the AD. Therefore, we investigated the effect of two acute stressors, immobilization (IMO) and lipopolysaccharide (LPS), on the AD-related neuropathology.
Alzheimer's disease is characterized by a progressive extracellular accumulation of amyloid β peptides and intraneuronal accumulation of the hyperphosphorylated tau protein in the brain of the AD patients. Neuroinflammation represents another classical hallmark of the AD. The role of the neuroinflammation in the AD pathogenesis indicate findings of inflammatory reaction in the brain regions implicated in development of AD (cortex and hippocampus) (Akiyama et al. 2000; Shen et al. 2016 ).
However, it is still a matter of debate whether neuroinflammation is the cause or only a consequence of the AD-related neuropathology. Several papers have indicated that subclinical neuroinflammation may be triggered by different factors that are implicated in the induction of the AD-related pathology, e.g. infection, toxic metabolites, brain injury, autoimmunity (Huang et al. 2017) , and stress (Wohleb et al. 2014; Le et al. 2016; Piirainen et al. 2017) .
Stress may induce AD-related neuropathology as well as neuroinflammation. Chronic stress may exacerbate amyloid β pathology (Baglietto-Vargas et al. 2015) . The production of toxic amyloid β proteins in the brain parenchyma and brain vessels depends on the cleavage of the amyloid precursor protein (APP) by active domain of β-site APP cleaving enzyme 1 (BACE-1) in the cell membrane (Muller et al. 2017) . High amyloid β levels are associated with increased levels of hormones implicated in stress conditions (Green et al. 2006; Catania et al. 2009 ) and stress hormone antagonism might significantly prevent the onset of the cognitive impairment and amyloid β aggregation in both the mice males and females without any toxicity (Zhang et al. 2016 ). In addition, stress-induced increase of the corticotropin-releasing hormone concentration in the brain can cause alterations in the phosphorylation of tau protein, and in turn affect the gene expression of tubulin β1 (TUBβ1) and microtubule-associated protein tau (MAPT) in the brain (Rissman et al. 2007; Filipcik et al. 2012 ). The tau phosphorylation was thought to be a downstream event of the amyloid β deposition. However, now, it is equally plausible that tau and amyloid β act in a parallel manner in the enhancement of each other's toxic effects and initiate the pathogenic events leading to the development of AD (Small and Duff 2008; Spires-Jones and Hyman 2014) . Finally, stress may modulate both central and peripheral inflammatory responses (Liu et al. 2017) .
It has been suggested that AD-related neuropathology can by induced by a chronic stress. However, several findings have indicated that also acute exposure to stressors may play a role (Rissman et al. 2007; Krstic et al. 2012) . To elucidate the role of the acute stress on the AD-related neuropathology, we exposed the mice either to a single IMO or LPS injection. In the brain cortex, we determined the expression of genes related to all three basic hallmarks of the AD: APP and BACE-1 implicated in amyloid β pathology, TUBβ1 and MAPT implicated in tau pathology, and inflammatory markers (interleukin 1β -IL-1β, interleukin 6 -IL-6, tumor necrosis factor α -TNFα). To elucidate the mechanisms responsible for the stressinduced neuroinflammation, we also determined several markers for the activity of the mononuclear cells (lymphocyte antigen 6 complex -LY6C, C-C chemokine receptor type 2 -CCR2, macrophage chemoattractant protein 1 -MCP1) and microglial activity (transforming growth factor β1 -TGFβ1, triggering receptor expressed on myeloid cells 2 -TREM2, C-X3-C motif chemokine receptor 1 -CX3CR1, cluster of differentiation 200 -CD200 and cluster of differentiation 200 receptor -CD200R).
Material and methods
Animals. Experiments were performed on 3-months old C57BL/6J male mice. Animals were housed 3-4 per cage and kept under controlled conditions in the animal facility of the Institute of Experimental Endocrinology (12 h light/12 h dark cycle, lights on at 06:00 h; temperature 22±1 °C, humidity 55±10%) with free access to tap water and standard pelleted chow. All experiments were performed between 09:00 and 11:00 h. All experimental procedures were approved by the Animal Care Committee of the Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia and State Veterinary and Food Administration of the Slovak Republic (Approval No. Ro-3400/13-221). The mice received care in compliance with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health.
Experimental protocol. Mice were randomly divided into three groups: a) CON -control mice strictly avoided of all the stress stimuli (n=7); b) IMO -mice exposed to 2 h immobilization (n=6); and c) LPS -mice intraperitoneally (i.p.) injected with LPS (250 µg/kg body weight) (n=6).
IMO group of animals was exposed to a single IMO for 2 h (Kvetnansky and Mikulaj 1970) and decapitated immediately after the termination of stressor exposure. LPS group of animals was i.p. injected by a single dose of LPS 250 µg/kg b.w. and decapitated 4 h after the LPS treatment, when the effect of LPS on immune system reaches the peak (White et al. 2017) .
Tissue sampling. Immediately after decapitation, the brains were removed and their cortices isolated. Then, the cortices samples of the brain were cooled in the liquid nitrogen and stored at -70 °C until used for analysis. The left cortical hemispheres were used for gene expression analyses.
RNA isolation, reverse transcription and Real Time PCR. Total RNA was isolated using the TRI ReagentVR RT (MRC, Inc., Cincinnati, OH) according to the manufacturer's protocol and concen-trations were quantified using the NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA). Reverse transcription of RNA (1500 ng from brain region tissue) was performed with the Illustra Ready-ToGo™ RT-PCR Beads (GE Healthcare, UK), according to the manufacturers' protocol. Semi-quantitative Real-Time PCR was set up in a total volume of 10 µl containing 500 ng of template cDNA mixed with 5 µl of SensiFast™ Sybr Hi-Rox Mix (Bioline, UK), 1 µl of specific self-designed primer pair set (Microsynth AG, Switzerland; sequences of used primers are shown in Table 1 ), and 2 µl of water. Each sample was analyzed on an ABI7900HT Fast Real-Time PCR instrument (Applied Biosystems, Foster City, CA) under the following conditions: one cycle of 2 min at 50 °C, followed by one cycle of initial denaturation for 2 min at 95 °C and then 40 cycles of denaturation (95 °C for 5 s) annealing and elongation (60 °C for 20 s). Data were obtained from software SDS 2.4 (Applied Biosystems, Foster City, CA) and normalized to TATA-binding protein (TBP) mRNA levels. Relative fold change was calculated using the ΔΔCt method (Schmittgen and Livak 2008) .
Statistical analysis. Results were evaluated by Student t-test and expressed as the mean ± SEM. Linear regression and Pearson's correlation coefficient were used to measure the statistical relationship, or association, between two continuous variables. Statistical analysis was performed using GraphPad Prism 8. Differences were considered statistically significant at p<0.05. Data are expressed as mean ± SEM and representing the mean for 6-7 mice.
Results
Comparing to CON (unstressed) animals, we found significantly increased gene expression of IL-1β (IMO p=0.0092; and LPS p=0.0011), IL-6 (IMO p<0.0001; LPS p=0.0031), TNFα (IMO p=0.0404; LPS p=0.0001) in the cortex of both experimental groups exposed to stressors (Figure 1) . LPS challenge significantly increased the expression of four genes implicated in AD-related neuropathology: APP (p=0.0086), BACE-1 (p=0.0056), TUBβ1 (p=0.0007) and MAPT (p=0.0184). IMO significantly increased the gene expression of APP (p=0.0463) and TUBβ1 (p=0.0447) (Figure 2 ). The linear regression revealed significant correlation between the levels of mRNA of APP and MAPT (IMO p=0.0261; LPS p=0.0412), APP and TUBβ1 (IMO p=0.0003; LPS p=0.0002), APP and IL-6 (IMO p=0.0018) and APP and TNFα (IMO p=0.0261; LPS p=0.0046) in the mice cortex (Figure 3) .
To elucidate the mechanisms responsible for the stress-induced inflammatory response, we determined gene expression of markers for the mononuclear cells (LY6C, CCR2, and MCP1). We found increased gene expression of LY6C in cortex of both stressed groups (IMO p=0.0493; LPS p<0.0001). Additionally, immobilized mice showed increased MCP1 mRNA (p=0.0224), whereas LPS-treated group showed increased gene expression of its receptor CCR2 (p=0.0052) (Figure 4) . Table 1  Table of To elucidate the cell type triggering LPS/IMOevoked inflammatory response, factors activating or inhibiting of activity of microglia, gene expression of TGFβ1, TREM2, CX3CR1, CD200, and CD200R was determined. However, gene expression of these factors did not show any significant changes in stressed animals ( Figure 5 ).
Discussion
The role of the stress as well as the pathways and mechanisms responsible for the stress-induced AD-related neuropathology still remains a matter of the debate. It has been shown that single restraint stress is sufficient to elevate the expression of inflam-
Figure 1. Gene expression of pro-inflammatory mediators in IMO exposed group (A) and LPS-treated group (B).
Mice were exposed to 2 h IMO or injected with 250 µg/kg b.w. LPS (white column -control group, n=7; black column -experimental treated groups, n=6). Each value represents the mean±SEM. The level of statistical significance *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 determines significant differences between control vs. experimental group. Abbreviations: IMO -immobilization; LPS -lipopolysaccharide; b.w. -body weight.
Figure 2. Expression of genes implicated in development of AD pathology in IMO exposed group (A) and LPStreated group (B).
Mice were exposed to 2 h IMO or injected with 250 µg/kg b.w. LPS (white column -control group, n=7; black column -experimental treated groups, both n=6). Each value represents the mean±SEM. The level of statistical significance *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 determines significant differences between control vs. experimental group. Abbreviations: AD -Alzheimer's disease; IMO -immobilization; LPS -lipopolysaccharide; b.w. -body weight. mation-related genes in the hippocampus in both BABLB/c and C57BL/6 mice (Sathyanesan et al. 2017 ).
In accordance with these studies, we hypothesize that the mechanisms of stress-induced AD-related changes may be evoked by the same effect as the immune challenge. We showed that LPS challenge can induce increase in the expression of APP, BACE-1, MAPT and TUBβ1 genes, implicated in the development of AD-related neuropathology, whereas IMO the expression of APP and TUBβ1 genes, in the mice cortex (Figure 2) . We found that increase of APP gene expression correlates with the increased gene expression of TUBβ1 and MAPT in both stressed groups ( Figure 3) and was followed by an increase in the inflammatory cytokines IL-1β, IL-6, and Figure 4 . Expression of mononuclear cell markers in IMO exposed group (A) and LPS-treated group (B). Mice were exposed to 2 h IMO or injected with 250 µg/kg b.w. LPS (white column -control group, n=7; black column -experimental treated groups, both n=6). Each value represents the mean±SEM. The level of statistical significance *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 determines significant differences between control vs. experimental group. Abbreviations: IMO -immobilization, LPS -lipopolysaccharide; b.w. -body weight.
Figure 5. Gene expression of microglial modulators in IMO exposed group (A) and LPS-treated group (B). Mice were exposed to 2 h IMO or injected with 250 µg/kg b.w. LPS (white column -control group, n=7; black column -experimental treated groups, both n=6). Each value represents the mean±SEM. The level of statistical significance *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 determines significant differences between control vs. experimental group. Abbreviations: IMO -immobilization, LPS -lipopolysaccharide; b.w. -body weight.
TNFα, in the mice cortex (Figure 1) . Importantly, TNF-α has been shown to stimulate the expression of APP and BACE-1 in the primary cultures of the mouse astrocytes (Zhao et al. 2011) . In addition, it has been demonstrated that IL-6 may potentiate the synthesis of the APP in neuronal human cells (Ringheim et al. 1998) , and conversely, IL-6 is upregulated in cultured rat glial cells upon stimulation with the carboxy-terminal 105 amino acids of APP (Chong 1997) . Our results are in accordance with studies proposing that systemic inflammation acts as a potent inducer of the AD-associated changes concerning the amyloid β and tau protein synthesis/modifications. It has been documented that experimental brain injury can induce expression of APP, which may be related to the neuronal loss in the hippocampus (Murakami et al. 1998) and that neurocognitive deficits in the hippocampus of middle aged rodents are linked to the intraperitoneal administration of the bacterial LPS (Liu et al. 2012) . More recent study has revealed an association between the AD development and the traumatic brain injury in humans (Marklund et al. 2014) . The importance of inflammatory pathways for the pathogenesis of AD is highlighted by the results of the genome-wide associated studies (GWAS), which indicate that many of the implicated genes play an important role in the immunological processes that regulate the phagocytosis and the activation state of the microglia/macrophages (Moraes et al. 2012) . It has been shown that microglia loses of its amyloid β clearing capabilities as the AD progresses (Lai and McLaurin 2012) . Microglial activity can be modulated by an active transport of cytokines and chemokines through the blood-brain barrier (Block et al. 2007) or passive transport of interleukins via the circumventricular organs (Nakano et al. 2015) . However, in our experimental model, there were no significant changes seen in the gene expression of markers studied indicating for the brain immune activity by neuronal CD200 and its microglial receptor CD200R (Yi et al. 2012) , or suppression of inflammatory cytokines release from microglia mediated by TREM2 (Mecca et al. 2018 ) ( Figure 5 ). Restricted expression of the chemokine receptor CX3CR1 in microglia (Wolf et al. 2013) , as one of the stress-responsive gene involved in neuroinflammation accompanying neurodegenerative tau pathology, has been described in rats (Novak et al. 2018 ). But we did not observe any changes in the expression of CX3CR1 in mice cortex indicating for a quiescent "sampling" or surveillance mode of microglia as it has previously been reviewed (Biber et al. 2007) . Taken together, our data indicate that microglia in the brain of stressed mice are in resting phase that can be similar to the microglial senescence in the AD patients (Guerriero et al. 2017) . We suggest that inflammatory response manifested by an increased expression of IL-1β, IL-6, TNFα and LY6C genes (Figure 1, Figure 4 ) in mice cortex is most likely mediated by activation of other immune cells, e.g. astrocytes, endothelial cells, perivascular macrophages, and/or peripheral monocytes within the blood-brain barrier (Erta et al. 2012) .
Important reactions of the perivascular perimeningeal macrophages and vascular endothelial cells can be triggered in the brain-periphery communication loop. It is likely that LPS-induced peripheral inflammation may cause neuroinflammatory reaction in the cortex via MCP1/CCR2 pathway, what can lead to an apoptosis (Bidzhekov et al. 2006; Zhou et al. 2006) . It is interesting that the IMO induces the same effect (Sathyanesan et al. 2017) . We found an increase of MCP1 gene expression without any changes in the gene expression of its receptor CCR2 in the cortex of IMO mice (Figure 4 ). Important role of MCP1 in AD pathology is supported by the evidence that MCP1 can enhance microglial amyloid β degradation, both in vivo and in vitro conditions. On the contrary, chronic expression of MCP1 has adverse effects on the amyloid β deposition (Yamamoto et al. 2005 (Yamamoto et al. , 2007 . Furthermore, elevated gene expression of CCR2 in LPS-treated group was observed simultaneously with the enhanced APP and TNFα mRNA production in the mice cortex. We hypothesize that increased gene expression of CCR2 during systemic inflammation might represent the first potent apoptotic signal in the LPS-induced neurodegenerative processes. Stimulation of MCP1/CCR2 apoptotic pathway has been shown to be driven by high levels of IL-6 and its receptor in the cell cultures (Modur et al. 1997 ) and mice (Romano et al. 1997) , which is comparable with the elevated IL-6 mRNA in IMO/ LPS groups.
Conclusions
We found that a single exposure to either IMO or LPS can elevate the gene expression of factors related to all three hallmarks of the AD, i.e. amyloid β and tau pathology and neuroinflammation. Our data indicate that both the stressors used may induce peripheral inflammation with consequent induction of neuroinflammation as well as other AD-related neuropathological changes. Importantly, we showed that even a single exposure to strong stressor is able to induce significant changes related to the AD-related neuropathology. Therefore, it can by hypothesized that repeated exposure to strong stressors (psychological, biological, and others) may have a cumulative effect, which may compromise the cellular and tissue homeostasis and thus participated on development of the AD.
